Zoetis stock slides for fourth straight day

10 articles · Updated · MarketWatch · May 6

Shares fell 1.17% to $111.22 on Wednesday, while the S&P 500 rose 1.46% and the Dow gained 1.24%.
The animal health company's stock closed 35.42% below its 52-week high of $172.23 reached on 3 June and lagged rivals Merck and IDEXX Laboratories.
Trading volume reached 5.3 million shares, above the 50-day average of 3.7 million, indicating heavier investor activity during the latest decline.

Is Zoetis's 35% stock plunge a historic buying opportunity or a warning sign of a deeper crisis?

With rivals soaring, can Zoetis's pipeline rescue it from the controversy threatening its blockbuster drugs?